-
Article
Selective photosynthesis of imines from biomass-derived aldehydes over Ni/TiO2
Photocatalytic reductive amination of biomass-derived aldehydes is a desirable way to selectively upgrade biomass into value-added nitrogen-containing chemicals under mild conditions. However, it is challengin...
-
Article
Open AccessEmergency tracheal intubation peri-operative risk factors and prognostic impact after esophagectomy
Emergent endotracheal intubation (ETI) is a serious complication after Oesophagectomy. It is still unclear that perioperative risk factors and prognosis of these patients with ETI.
-
Article
Non-invasive urinary metabolomic profiles discriminate biliary atresia from infantile hepatitis syndrome
Neonatal cholestatic disorders are a group of hepatobiliary diseases occurring in the first 3 months of life. The most common causes of neonatal cholestasis are infantile hepatitis syndrome (IHS) and biliary a...
-
Article
Open AccessDisturbance in Plasma Metabolic Profile in Different Types of Human Cytomegalovirus-Induced Liver Injury in Infants
Human cytomegalovirus (HCMV) infection in infants is a global problem and the liver is a target organ of HCMV invasion. However, the mechanism by which HCMV causes different types of liver injury is unclear, a...
-
Article
Erratum to: Negative feedback of miR-29 family TET1 involves in hepatocellular cancer
Primary hepatocellular carcinoma (HCC) is the most common form of liver cancer and is one of the most common malignancies worldwide. Tumor suppressor gene silencing through DNA methylation contributes to cance...
-
Article
Negative feedback of miR-29 family TET1 involves in hepatocellular cancer
Primary hepatocellular carcinoma (HCC) is the most common form of liver cancer and is one of the most common malignancies worldwide. Tumor suppressor gene silencing through DNA methylation contributes to cance...
-
Article
Protective effects of betaglucin on myocardial tissue during myocardial infarction in rats and dogs
To test the protective effects of betaglucin, a novel beta-glucan, on models of myocardial infarction (MI) in rats and dogs.